Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors
Jinglong Huang, Caifeng Gong, Aiping Zhou
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 11

Showing 11 citing articles:

From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Milk Bioactive Compounds and Gut Microbiota Modulation: The Role of Whey Proteins and Milk Oligosaccharides
Valentina Gallo, Alyexandra Arienzo, Federica Tomassetti, et al.
Foods (2024) Vol. 13, Iss. 6, pp. 907-907
Open Access | Times Cited: 15
Chitosan and its derivatives: A novel approach to gut microbiota modulation and immune system enhancement
Great Iruoghene Edo, Alice Njolke Mafe, Ali B. M. Ali, et al.
International Journal of Biological Macromolecules (2024) Vol. 289, pp. 138633-138633
Closed Access | Times Cited: 9
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
Immune checkpoint inhibitors and acute kidney injury
Ping Zhou, Ying Gao, Zhijuan Kong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Dietary methionine restriction in cancer development and antitumor immunity
Ming Ji, Qing Xu, Xiaoling Li
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 5, pp. 400-412
Closed Access | Times Cited: 5
The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond
Jessica R. Allegretti, Sahil Khanna, Benjamin H. Mullish, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 885-902
Closed Access | Times Cited: 5
Role of microbiome in cancer progression
Rinki Basoya, Baldeep Singh, Akshay Basi, et al.
International review of cell and molecular biology (2025)
Closed Access
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges
Marco Palma
Vaccines (2025) Vol. 13, Iss. 4, pp. 344-344
Open Access
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
Microbial Therapeutics in Oncology: A Comprehensive Review of Bacterial Role in Cancer Treatment
Radha Kunjalwar, Akshunna Keerti, Achal Chaudhari, et al.
Cureus (2024)
Open Access | Times Cited: 1
Page 1

Scroll to top